1. Home
  2. SCVL vs AUTL Comparison

SCVL vs AUTL Comparison

Compare SCVL & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shoe Carnival Inc.

SCVL

Shoe Carnival Inc.

HOLD

Current Price

$17.20

Market Cap

491.1M

ML Signal

HOLD

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.56

Market Cap

407.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCVL
AUTL
Founded
1978
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
491.1M
407.2M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
SCVL
AUTL
Price
$17.20
$1.56
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
418.7K
1.2M
Earning Date
05-29-2026
05-14-2026
Dividend Yield
3.72%
N/A
EPS Growth
N/A
N/A
EPS
1.90
N/A
Revenue
$1,135,324,000.00
$10,120,000.00
Revenue This Year
$1.64
$80.32
Revenue Next Year
$2.51
$53.96
P/E Ratio
$9.68
N/A
Revenue Growth
N/A
496.00
52 Week Low
$15.04
$1.15
52 Week High
$26.54
$2.70

Technical Indicators

Market Signals
Indicator
SCVL
AUTL
Relative Strength Index (RSI) 41.99 56.28
Support Level $16.80 $1.22
Resistance Level $18.37 $1.69
Average True Range (ATR) 0.72 0.08
MACD -0.06 -0.00
Stochastic Oscillator 12.14 57.63

Price Performance

Historical Comparison
SCVL
AUTL

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: